Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Medroxyprogesterone acetate |
Is a |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medroxyprogesterone adverse reaction |
Causative agent (attribute) |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to medroxyprogesterone |
Causative agent (attribute) |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing medroxyprogesterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Parenteral medroxyprogesterone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Medroxyprogesterone preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Medroxyprogesterone 150mg/ml injection 1ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medroxyprogesterone acetate 150mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estrogens, conjugated+medroxyprogesterone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely conjugated estrogens 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Conjugated estrogen- and medroxyprogesterone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to medroxyprogesterone |
Causative agent (attribute) |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely conjugated estrogens 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely conjugated estrogens 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Medroxyprogesterone acetate |
Is modification of (attribute) |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely conjugated estrogens 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing conjugated estrogen and medroxyprogesterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol- and medroxyprogesterone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol- and medroxyprogesterone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only conjugated estrogen and medroxyprogesterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol and medroxyprogesterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only medroxyprogesterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only estradiol and medroxyprogesterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Medroxyprogesterone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Conjugated estrogen and medroxyprogesterone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Medroxyprogesterone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing conjugated estrogen and esterified estrogen and medroxyprogesterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only conjugated estrogen and esterified estrogen and medroxyprogesterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing conjugated estrogen and esterified estrogen and medroxyprogesterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Conjugated estrogen and esterified estrogen and medroxyprogesterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Estradiol and medroxyprogesterone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol- and medroxyprogesterone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Medroxyprogesterone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |